Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer.

Michael A UlmTiffany M RedfernBen R WilsonSuriyan PonnusamySarah AsemotaPatrick W BlackburnYinan WangAdam C ElNaggarRamesh Narayanan

Published in: Journal of personalized medicine (2020)

Our initial findings validate ILK as a potential therapeutic target for molecular inhibition in ovarian cancer, which warrants further investigation.